Analysis and pharmacokinetics for drug development

Our services



Pharmaceutical Analysis

DNA/RNA Analysis

We are your partner for many kind of studies

Metabolism studies

Preclinical studies:

  • Dose-finding studies
  • Toxicological studies
  • Pharmacokinetic studies
  • Toxicokinetic studies
  • ADME or ADME-Tox studies
  • DMPK studies

Clinical trials (phases 0-III)

Bioequivalence/bioavailability studies

Biomarker development and validation

Biomarker studies

Stability studies

Enzyme activity studies

Biosimilar studies

Pharmacokinetic issues

You have questions or need more information

This is what our customers say

``Prolytic is our analytical partner throughout the entire drug development process. Such a long and complex process requires a laboratory you can trust. Professional yet flexible, Prolytic accompanies us through the preclinical and clinical phases.``- Omeicos Therapeutics GmbH
ÔÇ×Whether GLP-, GCP-analysis, method development work (non-GLP) or complex analytical questions, with Prolytic we have found a competent and trustworthy partner, with whom we are always happy to work with again.ÔÇŁ- MetrioPharm Deutschland GmbH